StockTipsArenaBeta

SELL Biocon Ltd — ICICI Securities

SELLBiocon Ltd
Biocon share price target & all analyst calls

byICICI SecuritiesHorizon: NA (inferred 1 year)14 Nov 2025via Institutional / Brokerage Research

Entry₹411.15Inferred
Target₹320
Total upside +22.17% (call closed)
Stop lossNot given
Exit₹32023 Oct 2026, 11:58 am
Target hit+22.17%0.00%upside left
Follow ICICI Securities for new calls(67% target hit, 1027 closed calls)Get alertsWatch BIOCON for new buy/sell callsGet alertsSee 10 active Long-term calls on BIOCONSee 278 active Long-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this SELL call — facts from public sources, machine-classified. Not investment advice.

As of 23 Oct, 7:17 pm IST
5 supporting12 neutral36 opposing
Supports the SELL call (5)

Eris Lifesciences drops 3% after acquiring India formulation business of Biocon arm

NewsGoogle News·18 Oct · 4d ago

(opens in new tab)

1 advisor has an active short-term SELL call on this stock, issued in the last 14 days

Advisor consensus · adjacent horizon·9 Oct · 2w ago

Neutral / worth noting (12)

Nothing found in this tip’s window yet.

Weighs against the SELL call (36)

Biocon settles licence agreement with Genetech for cancer treatment drug — Check earliest secured launch dates

NewsCnbc-Tv18·14 Oct · 1w ago

(opens in new tab)

Biocon Malaysia arm gets UK regulator approval for Semglee fill finish unit

NewsCnbc-Tv18·25 Sept · 4w ago

(opens in new tab)

1 advisor has an active short-term BUY call on this stock

Advisor consensus · adjacent horizon·19 Sept · 1mo ago

6 other SEBI-registered advisors have active long-term BUY calls on this stock

Advisor consensus · same horizon·7 Aug · 3mo ago

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Biocon

All analyst calls on Biocon

More from ICICI Securities

Every call and its outcome